Literature DB >> 24509415

GATA-2 inhibits transforming growth factor-β signaling pathway through interaction with Smad4.

Xiao-Ming Dong1, Rong-Hua Yin2, Yang Yang3, Zhi-Wei Feng2, Hong-Mei Ning4, Lan Dong5, Wei-Wei Zheng2, Liu-Jun Tang2, Jian Wang2, Yu-Xin Jia6, Yi-Nan Jiang7, En-Dong Liu7, Hui Chen2, Yi-Qun Zhan2, Miao Yu2, Chang-Hui Ge2, Chang-Yan Li8, Xiao-Ming Yang9.   

Abstract

GATA-2, a member of zinc finger GATA transcription factor family, plays key role in the hematopoietic stem cells self-renewal and differentiation. The transforming growth factor-β (TGFβ) signaling pathway is a major signaling network that controls cell proliferation, differentiation and tumor suppression. Here we found that GATA-2 negatively regulated TGF-β signaling pathway in Smad4-dependent manner. GATA-2 specifically interacts with Smad4 with its N-terminal while the zinc finger domain of GATA-2 is essential for negative regulation of TGFβ. Although GATA-2 did not affect the phosphorylation of Smad2/3 and the complex Smad2/3/4 formation in response to TGFβ, the DNA binding activity of Smad4 was decreased significantly by GATA-2 overexpression. Overexpression of GATA-2 in K562 cells led to reduced TGFβ-induced erythroid differentiation while knockdown of GATA-2 enhanced TGFβ-induced erythroid differentiation. All these results suggest that GATA-2 is a novel negative regulator of TGFβ signal pathway.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Erythroid differentiation; GATA-2; Smad4; TGF-β signaling pathway

Mesh:

Substances:

Year:  2014        PMID: 24509415     DOI: 10.1016/j.cellsig.2014.01.028

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  6 in total

1.  MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediation.

Authors:  Yufeng Jiang; Chao Wu; Alex Boye; Jiajun Wu; Jiyu Wang; Xiaochuan Yang; Yan Yang
Journal:  Mol Cell Biochem       Date:  2015-05-13       Impact factor: 3.396

2.  Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients.

Authors:  Bryce A Manso; Henan Zhang; Molly G Mikkelson; Kimberly A Gwin; Charla R Secreto; Wei Ding; Sameer A Parikh; Neil E Kay; Kay L Medina
Journal:  Leukemia       Date:  2018-10-05       Impact factor: 11.528

Review 3.  Haematopoietic and immune defects associated with GATA2 mutation.

Authors:  Matthew Collin; Rachel Dickinson; Venetia Bigley
Journal:  Br J Haematol       Date:  2015-02-23       Impact factor: 6.998

4.  Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program.

Authors:  Maike Frye; Andrea Taddei; Cathrin Dierkes; Ines Martinez-Corral; Matthew Fielden; Henrik Ortsäter; Jan Kazenwadel; Dinis P Calado; Pia Ostergaard; Marjo Salminen; Liqun He; Natasha L Harvey; Friedemann Kiefer; Taija Mäkinen
Journal:  Nat Commun       Date:  2018-04-17       Impact factor: 14.919

5.  Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocarcinogenesis via modulating TGF-β/TβR and Imp7/8.

Authors:  Chao Wu; Hongwei Kan; Min Hu; Xin Liu; Alex Boye; Yufeng Jiang; Jiajun Wu; Jiyu Wang; Xiaochuan Yang; Yan Yang
Journal:  Exp Ther Med       Date:  2018-06-12       Impact factor: 2.447

6.  A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes.

Authors:  Jennifer F Doss; David L Corcoran; Dereje D Jima; Marilyn J Telen; Sandeep S Dave; Jen-Tsan Chi
Journal:  BMC Genomics       Date:  2015-11-16       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.